Volgen
Mark Gresnigt
Mark Gresnigt
Junior Research Group Adaptive Pathogenicity Strategies, Hans Knöll Institut, Leibniz Institute for
Geverifieerd e-mailadres voor leibniz-hki.de - Homepage
Titel
Geciteerd door
Geciteerd door
Jaar
A guiding map for inflammation
MG Netea, F Balkwill, M Chonchol, F Cominelli, MY Donath, ...
Nature immunology 18 (8), 826-831, 2017
6552017
Broad defects in the energy metabolism of leukocytes underlie immunoparalysis in sepsis
SC Cheng, BP Scicluna, RJW Arts, MS Gresnigt, E Lachmandas, ...
Nature immunology 17 (4), 406-413, 2016
5042016
Aspergillus fumigatus morphology and dynamic host interactions
FL Van De Veerdonk, MS Gresnigt, L Romani, MG Netea, JP Latgé
Nature Reviews Microbiology 15 (11), 661-674, 2017
4302017
IL-1 receptor blockade restores autophagy and reduces inflammation in chronic granulomatous disease in mice and in humans
A de Luca, SP Smeekens, A Casagrande, R Iannitti, KL Conway, ...
Proceedings of the National Academy of Sciences 111 (9), 3526-3531, 2014
3062014
The itaconate pathway is a central regulatory node linking innate immune tolerance and trained immunity
J Domínguez-Andrés, B Novakovic, Y Li, BP Scicluna, MS Gresnigt, ...
Cell metabolism 29 (1), 211-220. e5, 2019
2762019
Interferon-gamma as adjunctive immunotherapy for invasive fungal infections: a case series
CE Delsing, MS Gresnigt, J Leentjens, F Preijers, FA Frager, M Kox, ...
BMC infectious diseases 14, 1-12, 2014
2532014
Integrated transcriptomic and proteomic analyses of P. falciparum gametocytes: molecular insight into sex-specific processes and translational repression
E Lasonder, SR Rijpma, BCL van Schaijk, WAM Hoeijmakers, ...
Nucleic acids research 44 (13), 6087-6101, 2016
2512016
Biology of IL-36 cytokines and their role in disease
MS Gresnigt, FL van de Veerdonk
Seminars in immunology 25 (6), 458-465, 2013
2192013
Aspergillus cell wall melanin blocks LC3-associated phagocytosis to promote pathogenicity
T Akoumianaki, I Kyrmizi, I Valsecchi, MS Gresnigt, G Samonis, E Drakos, ...
Cell host & microbe 19 (1), 79-90, 2016
2112016
The fungal peptide toxin Candidalysin activates the NLRP3 inflammasome and causes cytolysis in mononuclear phagocytes
L Kasper, A König, PA Koenig, MS Gresnigt, J Westman, RA Drummond, ...
Nature communications 9 (1), 4260, 2018
2002018
The impact of the Fungus-Host-Microbiota interplay upon Candida albicans infections: current knowledge and new perspectives
C d'Enfert, AK Kaune, LR Alaban, S Chakraborty, N Cole, M Delavy, ...
FEMS microbiology reviews 45 (3), fuaa060, 2021
1992021
Functional genomics identifies type I interferon pathway as central for host defense against Candida albicans
SP Smeekens, A Ng, V Kumar, MD Johnson, TS Plantinga, C Van Diemen, ...
Nature communications 4 (1), 1342, 2013
1932013
Th17 responses and host defense against microorganisms: an overview
FL Van De Veerdonk, MS Gresnigt, BJ Kullberg, JWM Van Der Meer, ...
BMB reports 42 (12), 776-787, 2009
1742009
Corticosteroids block autophagy protein recruitment in Aspergillus fumigatus phagosomes via targeting dectin-1/Syk kinase signaling
I Kyrmizi, MS Gresnigt, T Akoumianaki, G Samonis, P Sidiropoulos, ...
The Journal of Immunology 191 (3), 1287-1299, 2013
1382013
Rewiring cellular metabolism via the AKT/mTOR pathway contributes to host defence against Mycobacterium tuberculosis in human and murine cells
E Lachmandas, M Beigier‐Bompadre, SC Cheng, V Kumar, ...
European journal of immunology 46 (11), 2574-2586, 2016
1352016
A Polysaccharide Virulence Factor from Aspergillus fumigatus Elicits Anti-inflammatory Effects through Induction of Interleukin-1 Receptor Antagonist
MS Gresnigt, S Bozza, KL Becker, LAB Joosten, S Abdollahi-Roodsaz, ...
PLoS pathogens 10 (3), e1003936, 2014
1332014
The IL‐36 receptor pathway regulates Aspergillus fumigatus‐induced Th1 and Th17 responses
MS Gresnigt, B Rösler, CWM Jacobs, KL Becker, LAB Joosten, ...
European journal of immunology 43 (2), 416-426, 2013
1212013
The gut, the bad and the harmless: Candida albicans as a commensal and opportunistic pathogen in the intestine
CA Kumamoto, MS Gresnigt, B Hube
Current opinion in microbiology 56, 7-15, 2020
1172020
Immunotherapeutic approaches to treatment of fungal diseases
D Armstrong-James, GD Brown, MG Netea, T Zelante, MS Gresnigt, ...
The Lancet Infectious Diseases 17 (12), e393-e402, 2017
1162017
A three-dimensional immunocompetent intestine-on-chip model as in vitro platform for functional and microbial interaction studies
M Maurer, MS Gresnigt, A Last, T Wollny, F Berlinghof, R Pospich, ...
Biomaterials 220, 119396, 2019
1142019
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20